Ning Jiang, M.D./Ph.D.
1 clinical trials · Sponsor
◉ Watch Ning Jiang, M.D./Ph.D.
| Record | Firm | Date |
|---|---|---|
| Short-Course Definitive Chemoradiotherapy Combined With Adjuvant or Concurrent Plus Adjuvant Camrelizumab for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (NCT07530094) | Ning Jiang, M.D./Ph.D. | 2025-12-01 |
Track Ning Jiang, M.D./Ph.D. automatically
Every clearance here is in the API, with alerts when new ones post.